Kalaris Therapeutics, Inc. — All Filings
661 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B3
424B4
424B5
425
5
8-A12B
8-A12B/A
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEL AM
DRS
EFFECT
POS AM
POSASR
PRE 14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0001193125-26-119707 | Mar 23, 2026 | Mar 19, 2026 |
| 144 | — | 0001950047-26-002859 | Mar 20, 2026 | — |
| 4 | 4 | 0001193125-26-117617 | Mar 20, 2026 | Mar 19, 2026 |
| 4 | 4 | 0001193125-26-117618 | Mar 20, 2026 | Mar 19, 2026 |
| 4 | 4 | 0001193125-26-117616 | Mar 20, 2026 | Mar 19, 2026 |
| 10-K | 10-K | 0001193125-26-110659 | Mar 17, 2026 | Dec 31, 2025 |
| S-8 | S-8 | 0001193125-26-111180 | Mar 17, 2026 | — |
| 8-K | 8-K | 0001193125-26-109437 | Mar 17, 2026 | — |
| 8-K | 8-K | 0001193125-26-097548 | Mar 9, 2026 | — |
| 4 | — | 0001231919-26-000166 | Feb 17, 2026 | Dec 18, 2025 |
| SCHEDULE 13G | — | 0001493215-26-000038 | Feb 17, 2026 | — |
| SCHEDULE 13D/A | — | 0001699737-26-000007 | Feb 17, 2026 | — |
| 4 | — | 0001231919-25-000652 | Dec 22, 2025 | — |
| SCHEDULE 13D/A | — | 0001699737-25-000032 | Dec 22, 2025 | — |
| 8-K | 8-K | 0001193125-25-323706 | Dec 18, 2025 | Dec 17, 2025 |
| 8-K | 8-K | 0001193125-25-322950 | Dec 17, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-277464 | Nov 12, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-276060 | Nov 12, 2025 | — |
| 4 | 4 | 0001193125-25-262831 | Nov 3, 2025 | — |
| 8-K | 8-K | 0001193125-25-261697 | Nov 3, 2025 | Oct 28, 2025 |
| 3 | 3 | 0001193125-25-262823 | Nov 3, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-107979 | Aug 13, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001193125-25-179464 | Aug 13, 2025 | — |
| 8-K | 8-K | 0001193125-25-179466 | Aug 13, 2025 | Aug 12, 2025 |
| SCHEDULE 13G/A | — | 0002005369-25-000004 | Jul 29, 2025 | — |
| ARS | ARS | 0001193125-25-153445 | Jul 1, 2025 | Dec 31, 2024 |
| DEF 14A | DEF 14A | 0001193125-25-153439 | Jul 1, 2025 | Aug 12, 2025 |
| DEFA14A | DEFA14A | 0001193125-25-153441 | Jul 1, 2025 | — |
| 8-K | 8-K | 0001193125-25-143202 | Jun 20, 2025 | Jun 19, 2025 |
| S-8 | S-8 | 0001193125-25-134898 | Jun 4, 2025 | — |
| SCHEDULE 13G/A | — | 0000935836-25-000363 | May 15, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-071339 | May 14, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001193125-25-119408 | May 14, 2025 | — |
| 8-K | 8-K | 0001193125-25-082819 | Apr 16, 2025 | Apr 10, 2025 |
| 4 | 4 | 0000950170-25-053330 | Apr 11, 2025 | Apr 10, 2025 |
| 4 | 4 | 0000950170-25-053358 | Apr 11, 2025 | Apr 10, 2025 |
| 4 | 4 | 0000950170-25-053318 | Apr 11, 2025 | Apr 10, 2025 |
| 4 | 4 | 0000950170-25-053379 | Apr 11, 2025 | Apr 10, 2025 |
| 4 | 4 | 0000950170-25-053338 | Apr 11, 2025 | Apr 10, 2025 |
| 4 | 4 | 0000950170-25-053339 | Apr 11, 2025 | Apr 10, 2025 |
| 4 | 4 | 0000950170-25-053347 | Apr 11, 2025 | Apr 10, 2025 |
| 4 | 4 | 0000950170-25-053382 | Apr 11, 2025 | Apr 10, 2025 |
| 4 | 4 | 0000950170-25-053368 | Apr 11, 2025 | Apr 10, 2025 |
| 4 | 4 | 0000950170-25-053369 | Apr 11, 2025 | Apr 10, 2025 |
| 4 | 4 | 0000950170-25-053372 | Apr 11, 2025 | Apr 10, 2025 |
| 3 | 3 | 0000950170-25-050883 | Apr 4, 2025 | Apr 3, 2025 |
| 8-K | 8-K | 0001193125-25-072869 | Apr 4, 2025 | Apr 3, 2025 |
| 4 | 4 | 0000950170-25-046263 | Mar 27, 2025 | Mar 26, 2025 |
| 3/A | 3/A | 0000950170-25-045429 | Mar 26, 2025 | Mar 18, 2025 |
| SCHEDULE 13D | — | 0001415889-25-008979 | Mar 25, 2025 | — |